Physician
Internal Medicine
Dr. Michael W. Swartout, MD
Michael W. Swartout is an expert in the field of Internal Medicine. He attended Washington University School of Medicine in St. Louis. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael W. Swartout is also published. He has 6 publications published. The lastest publication: "Translocations, the predominant cause of total sterility in sons of mice treated with mutagens.' He accepts all Medicare patients.
Publications
Schools
Washington Center School of Medicine
University Calif
Doctors Specialties
Accepted Insurances
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Enhanced Exclusive for Small Business HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF
-
Washington University School of Medicine in St. Louis
Drug Facts
NPI NUMBER |
|
1013931146 |
NPPES Provider LastName |
|
SWARTOUT |
NPPES Provider FirstName |
|
MICHAEL |
NPPES Provider ZIPCode |
|
930602511 |
NPPES Provider State |
|
CA |
Specialty Description |
|
Internal Medicine |
Total Claim Count |
|
12133.0 |
Distinct Opioid Count |
|
4.0 |
Opioid Claim Count |
|
457.0 |
Percent Opioid Claims |
|
3.77 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1013931146 |
Last Name Of The Provider |
SWARTOUT |
First Name Of The Provider |
MICHAEL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog